SenesTech (NASDAQ:SNES) Receives New Coverage from Analysts at assumed coverage on shares of SenesTech (NASDAQ:SNESFree Report) in a report issued on Monday morning. The brokerage issued a sell rating on the stock.

Separately, HC Wainwright restated a buy rating and set a $3.50 price target on shares of SenesTech in a report on Tuesday, May 14th.

View Our Latest Research Report on SenesTech

SenesTech Price Performance

Shares of NASDAQ:SNES opened at $0.67 on Monday. SenesTech has a 52-week low of $0.52 and a 52-week high of $16.08. The business has a fifty day moving average of $0.74 and a two-hundred day moving average of $0.85. The company has a debt-to-equity ratio of 0.03, a quick ratio of 5.69 and a current ratio of 6.91.

SenesTech (NASDAQ:SNESGet Free Report) last announced its quarterly earnings data on Thursday, May 9th. The company reported ($0.36) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.34) by ($0.02). SenesTech had a negative net margin of 545.82% and a negative return on equity of 181.46%. The firm had revenue of $0.42 million during the quarter, compared to analysts’ expectations of $0.43 million. During the same period in the prior year, the company posted ($15.85) EPS. As a group, sell-side analysts predict that SenesTech will post -1.1 EPS for the current fiscal year.

Hedge Funds Weigh In On SenesTech

A hedge fund recently bought a new stake in SenesTech stock. McAdam LLC acquired a new stake in SenesTech, Inc. (NASDAQ:SNESFree Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 64,348 shares of the company’s stock, valued at approximately $44,000. McAdam LLC owned 1.25% of SenesTech at the end of the most recent quarter. Institutional investors own 5.19% of the company’s stock.

SenesTech Company Profile

(Get Free Report)

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

See Also

Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with's FREE daily email newsletter.